Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Flash flood warnings: National Weather Service issues a flash flood warning for Vance, Granville and Person counties until 2:15 a.m. Thursday
Just In
Flood advisories: Person, Granville, Vance, Warren, Halifax, Franklin, Nash & parts of Durham & Orange counties under advisory until 1:30 a.m.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alcon Inc
(NY:
ALC
)
90.00
-0.26 (-0.29%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
946,093
Open
88.90
Bid (Size)
89.18 (2)
Ask (Size)
97.57 (1)
Prev. Close
90.26
Today's Range
88.79 - 90.67
52wk Range
69.44 - 92.65
Shares Outstanding
489,219,355
Dividend Yield
0.26%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via
Benzinga
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
June 24, 2024
From
Alcon Inc. Investors
Via
Business Wire
Performance
YTD
+16.82%
+16.82%
1 Month
+1.75%
+1.75%
3 Month
+13.92%
+13.92%
6 Month
+17.72%
+17.72%
1 Year
+6.17%
+6.17%
More News
Read More
ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q1 2024
May 20, 2024
Via
InvestorPlace
Do You Have Your Eye On Vision Care Stocks?
May 20, 2024
Via
Talk Markets
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
May 19, 2024
Via
Benzinga
Alcon Analysts Increase Their Forecasts Following Q1 Results
May 15, 2024
Via
Benzinga
Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning
March 12, 2024
Via
Investor Brand Network
Contact Lens Maker Alcon's Has New Growth Avenues, Analyst Upgrades Stock
May 15, 2024
Via
Benzinga
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 14, 2024
Via
Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
Via
Benzinga
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
May 14, 2024
Via
Benzinga
2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
May 14, 2024
Via
Talk Markets
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
May 13, 2024
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2024 Annual General Meeting
May 08, 2024
From
Alcon Inc. Investors
Via
Business Wire
What 6 Analyst Ratings Have To Say About Alcon
December 04, 2023
Via
Benzinga
Star Surgical Shines as U.S. Outlook Improves for 2024
April 16, 2024
Via
MarketBeat
Alcon Publishes Agenda for 2024 Annual General Meeting
April 07, 2024
From
Alcon Inc. Investors
Via
Business Wire
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
March 06, 2024
From
Alcon Inc. Corporate
Via
Business Wire
Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
February 27, 2024
From
Alcon Inc. Investors
Via
Business Wire
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
February 09, 2024
Via
Benzinga
Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key'
January 23, 2024
Via
Benzinga
Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials
January 10, 2024
Via
Benzinga
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
January 09, 2024
From
Alcon Inc. Investors
Via
Business Wire
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.